Browsing Tag
Boston Scientific
28 posts
Can AI predict heart failure years earlier? Inside Anumana’s breakthrough AHA 2025 results
Anumana’s FDA-cleared ECG-AI platform enhances heart failure prediction and expands into perioperative care with Boston Scientific’s backing. Learn more.
Boston Scientific to take full control of Nalu Medical in $533m chronic pain tech deal
Boston Scientific is acquiring Nalu Medical for $533M to expand its pain therapy portfolio with a miniaturized, wearable neurostimulation system. Learn what this means.
Is neuromodulation entering its next growth cycle? Lessons from Medtronic, Axonics, and Boston Scientific
Neuromodulation is moving into its next growth cycle. Explore how Medtronic, Boston Scientific, and Axonics are reshaping bladder control and chronic care.
From stigma to scale: How bladder control therapies are evolving from hidden struggle to healthcare priority
Bladder control therapies are moving from stigma to mainstream care. Discover how rising awareness and innovation are reshaping treatment options globally.
Boston Scientific to expand cardiovascular portfolio with Bolt Medical acquisition
Boston Scientific Corporation has announced a definitive agreement to acquire Bolt Medical, Inc., a developer of cutting-edge intravascular…
FDA greenlights Medtronic’s dual-energy ablation—could this be the future of AFib treatment?
Medtronic has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting approval for its…
Boston Scientific to acquire Silk Road Medical for $1.2bn to enhance stroke prevention capabilities
Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK)…
Boston Scientific to enhance urology portfolio by acquiring Axonics in $3.7bn deal
Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a…
Boston Scientific to buy medical technology company Relievant Medsystems for $850m
Boston Scientific Corporation has struck a definitive deal to purchase Relievant Medsystems for an upfront payment of $850…
Boston Scientific to take majority stake in Acotec Scientific for $523m
Boston Scientific, a US medical device maker, has offered to acquire a stake of up to 65% in…